Protein tyrosine kinase (PTK) (PTK)

The tyrosine kinase domain is a highly conserved protein structure responsible for the catalytic activity of protein tyrosine kinases (PTKs) [PMID: 12696678]. These enzymes catalyze the transfer of a phosphate group from ATP to specific tyrosine residues on target proteins, a process fundamental to intracellular signaling [UniProt: P00533]. PTKs are divided into two main classes: receptor tyrosine kinases (RTKs), which span the cell membrane, and non-receptor tyrosine kinases (nRTKs), which are located within the cytoplasm or nucleus [StatPearls: NBK542218]. In healthy cells, the activity of this domain is tightly regulated to control essential processes such as cell proliferation, differentiation, and survival [PMID: 11902574]. However, mutations or over-expression leading to constitutive activation of the tyrosine kinase domain are primary drivers in various malignancies and inflammatory disorders [PubMed: 30030515]. Consequently, this domain is a major focus of pharmaceutical research, with numerous small-molecule inhibitors designed to bind the ATP-binding pocket and block signaling [PubChem: CID 5288]. While highly effective, the structural similarity of the kinase domain across different proteins often leads to challenges regarding drug selectivity and the development of acquired resistance [PMID: 25291298].

Other names

Tyrosine-protein kinaseTyrosine kinaseTK domainPhosphotransferaseTyrosine kinase domain

Small-molecule inhibitors typically act as ATP-competitive antagonists, binding to the ATP-binding pocket within the tyrosine kinase domain to prevent the phosphorylation of tyrosine residues on substrate proteins, thereby halting downstream signaling cascades [PMID: 12696678, StatPearls: NBK542218].